  Cellular heterogeneity is important to biological processes, including cancer
and development. However, proteome heterogeneity is largely unexplored because
of the limitations of existing methods for quantifying protein levels in single
cells. To alleviate these limitations, we developed Single Cell ProtEomics by
Mass Spectrometry (SCoPE-MS), and validated its ability to identify distinct
human cancer cell types based on their proteomes. We used SCoPE-MS to quantify
over a thousand proteins in differentiating mouse embryonic stem (ES) cells.
The single-cell proteomes enabled us to deconstruct cell populations and infer
protein abundance relationships. Comparison between single-cell proteomes and
transcriptomes indicated coordinated mRNA and protein covariation. Yet many
genes exhibited functionally concerted and distinct regulatory patterns at the
mRNA and the protein levels, suggesting that post-transcriptional regulatory
mechanisms contribute to proteome remodeling during lineage specification,
especially for developmental genes. SCoPE-MS is broadly applicable to measuring
proteome configurations of single cells and linking them to functional
phenotypes, such as cell type and differentiation potentials.
